Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al

Detalles Bibliográficos
Autores principales: Viswanathan, Vidya Sankar, Khorrami, Mohammadhadi, Jazieh, Khalid, Fu, Pingfu, Pennell, Nathan, Madabhushi, Anant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157364/
https://www.ncbi.nlm.nih.gov/pubmed/35640931
http://dx.doi.org/10.1136/jitc-2022-005086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157364/
https://www.ncbi.nlm.nih.gov/pubmed/35640931
http://dx.doi.org/10.1136/jitc-2022-005086

Ejemplares similares